Literature DB >> 23052954

Posterior reversible encephalopathy syndrome in critically ill children: a case series.

Tai-Heng Chen, Shyh-Shin Chiou, Wei-Chen Lin, I-Fan Wang, I-Chen Chen, Zen-Kong Dai, Jiunn-Ren Wu, Jong-Hau Hsu.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23052954     DOI： 10.1007/s00134-012-2705-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Patient-, provider-, and clinic-level predictors of unrecognized elevated blood pressure in children.

Authors:  Tammy M Brady; Barry S Solomon; Alicia M Neu; George K Siberry; Rulan S Parekh
Journal:  Pediatrics       Date:  2010-05-03       Impact factor: 7.124

2.  Acute glomerulonephritis presenting with PRES: a report of 4 cases.

Authors:  E C Wirrell; L D Hamiwka; L A Hamiwka; S Grisaru; X Wei
Journal:  Can J Neurol Sci       Date:  2007-08       Impact factor: 2.104

3.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

4.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  Vivien H Lee; Eelco F M Wijdicks; Edward M Manno; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-02

5.  Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients.

Authors:  Giuseppe Servillo; Pasquale Striano; Salvatore Striano; Fabio Tortora; Patrizia Boccella; Edoardo De Robertis; Flavia Rossano; Francesco Briganti; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2003-08-06       Impact factor: 17.440
  5 in total
  1 in total

1.  Pediatric posterior reversible encephalopathy syndrome presenting with isolated cerebellar edema and obstructive hydrocephalus.

Authors:  Nicholas Ettinger; Matthew Pearson; Fred S Lamb; John C Wellons
Journal:  J Neurosurg Pediatr       Date:  2014-07-25       Impact factor: 2.375
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.